Tamoxifen
DrugBank ID: DB00675
Summary
| Metric | Value |
|---|---|
| Total Predictions | 51 |
| KG+DL (Dual Validated) | 2 |
| DL Only | 48 |
| KG Only | 1 |
Predictions
| Indication | Score | Source |
|---|---|---|
| female breast carcinoma | 0.9995 | KG+DL |
| mammary Paget disease | 0.9969 | DL |
| intraductal cribriform breast adenocarcinoma | 0.9969 | DL |
| basal-like breast carcinoma | 0.9968 | DL |
| breast carcinoma in situ | 0.9967 | DL |
| sebaceous breast carcinoma | 0.9967 | DL |
| invasive tubular breast carcinoma | 0.9967 | DL |
| Ehrlich tumor carcinoma | 0.9967 | DL |
| estrogen-receptor positive breast cancer | 0.9967 | DL |
| hormone-resistant breast carcinoma | 0.9967 | DL |
| botryoid-type embryonal rhabdomyosarcoma of the vagina | 0.9967 | DL |
| estrogen-receptor negative breast cancer | 0.9966 | DL |
| adenoid cystic breast carcinoma | 0.9966 | DL |
| medullary breast carcinoma | 0.9965 | DL |
| scirrhous breast carcinoma | 0.9965 | DL |
| prostate cancer/brain cancer susceptibility | 0.9965 | DL |
| lobular breast carcinoma in situ | 0.9965 | DL |
| oncocytic breast carcinoma | 0.9965 | DL |
| adenocarcinoma in situ | 0.9964 | DL |
| mucoepidermoid breast carcinoma | 0.9964 | DL |
| breast malignant eccrine spiradenoma | 0.9964 | DL |
| invasive ductal and lobular carcinoma | 0.9964 | DL |
| signet ring cell breast carcinoma | 0.9963 | DL |
| breast intraductal proliferative lesion | 0.9963 | DL |
| fibroma of prostate | 0.9962 | DL |
| dermatofibrosarcoma protuberans | 0.9962 | DL |
| breast mucinous cystadenocarcinoma | 0.9962 | DL |
| bilateral breast carcinoma | 0.9961 | DL |
| parameningeal embryonal rhabdomyosarcoma | 0.9961 | DL |
| embryonal extrahepatic bile duct rhabdomyosarcoma | 0.9961 | DL |
| Brenner tumor | 0.9961 | DL |
| breast ductal adenocarcinoma | 0.9960 | KG+DL |
| benign reproductive system neoplasm | 0.9960 | DL |
| rhabdomyosarcoma (disease) | 0.9959 | DL |
| prostate leiomyoma | 0.9959 | DL |
| breast carcinoma by gene expression profile | 0.9959 | DL |
| prostate embryonal rhabdomyosarcoma | 0.9959 | DL |
| breast secretory carcinoma | 0.9958 | DL |
| extrahepatic bile duct rhabdomyosarcoma | 0.9958 | DL |
| male reproductive organ cancer | 0.9957 | DL |
| fibroblastic neoplasm | 0.9957 | DL |
| liver sarcoma | 0.9956 | DL |
| heart fibrosarcoma | 0.9955 | DL |
| liposarcoma | 0.9954 | DL |
| benign prostate phyllodes tumor | 0.9954 | DL |
| kidney fibrosarcoma | 0.9953 | DL |
| ovarian myxoid liposarcoma | 0.9952 | DL |
| breast columnar cell mucinous carcinoma | 0.9952 | DL |
| nipple carcinoma | 0.9952 | DL |
| clear cell renal carcinoma | 0.9951 | DL |
Showing top 50 of 51 predictions.
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.